JoVE Logo

S'identifier

4.14 : Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Tags

AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

Du chapitre 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

8.2K Vues

article

4.1 : Principes de l’action des médicaments

Pharmacodynamics

5.7K Vues

article

4.2 : Cibles d’action médicamenteuse : Vue d’ensemble

Pharmacodynamics

6.0K Vues

article

4.3 : Transduction du signal : Vue d’ensemble

Pharmacodynamics

8.1K Vues

article

4.4 : Mécanisme du transducteur : récepteurs couplés aux protéines G

Pharmacodynamics

1.8K Vues

article

4.5 : Récepteur de canal ionique ligand-dépendant : mécanisme de déclenchement

Pharmacodynamics

2.1K Vues

article

4.6 : Mécanisme du transducteur : récepteurs enzymatiques

Pharmacodynamics

2.3K Vues

article

4.7 : Mécanisme du transducteur : récepteurs nucléaires

Pharmacodynamics

1.3K Vues

article

4.8 : Relation dose-réponse : aperçu

Pharmacodynamics

2.9K Vues

article

4.9 : Relation dose-réponse : puissance et efficacité potentielle

Pharmacodynamics

4.2K Vues

article

4.10 : Relation dose-réponse : sélectivité et spécificité

Pharmacodynamics

6.4K Vues

article

4.11 : Indice thérapeutique

Pharmacodynamics

4.0K Vues

article

4.12 : Interaction médicament-récepteur : agoniste

Pharmacodynamics

2.3K Vues

article

4.13 : Interaction médicament-récepteur : antagoniste

Pharmacodynamics

2.7K Vues

article

4.15 : Effets combinés des médicaments : synergie

Pharmacodynamics

3.7K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.